新闻/Reuters/Cybin Announces Additional U.S. Patent Supporting Its CYB003 Breakthrough Therapy Program In Phase 3 Development For Major Depressive D…Cybin Announces Additional U.S. Patent Supporting Its CYB003 Breakthrough Therapy Program In Phase 3 Development For Major Depressive DisorderRefinitiv阅读少于1分钟CYBNCybin Inc CYBN:CYBIN ANNOUNCES ADDITIONAL U.S. PATENT SUPPORTING ITS CYB003 BREAKTHROUGH THERAPY PROGRAM IN PHASE 3 DEVELOPMENT FOR MAJOR DEPRESSIVE DISORDERReuters加拿大股票美国股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
